Ani Pharmaceuticals (ANIP) Share-based Compensation Growth (3y) (2014 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | 10.06% |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | -8.13% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -7.97% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | -70.06% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 17.84% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 29.52% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 53.88% |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | 12.93% |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.52% |
| Mar 31, 2026 | 32.94% |
| Dec 31, 2025 | 37.75% |
| Sep 30, 2025 | 103.50% |
| Jun 30, 2025 | 103.28% |
| Mar 31, 2025 | 39.92% |
| Dec 31, 2024 | 33.50% |
| Sep 30, 2024 | 39.12% |
| Jun 30, 2024 | 116.31% |
| Mar 31, 2024 | 54.81% |
| Dec 31, 2023 | 32.93% |
| Sep 30, 2023 | 32.30% |
| Jun 30, 2023 | 91.88% |
| Mar 31, 2023 | 21.41% |
| Dec 31, 2022 | 15.21% |
| Sep 30, 2022 | 13.96% |
| Jun 30, 2022 | -20.83% |
| Mar 31, 2022 | 10.24% |
| Dec 31, 2021 | 17.53% |
| Sep 30, 2021 | 54.01% |